RESUMEN
Non-small cell lung cancer (NSCLC) patients with EGFR mutations initially respond well to EGFR tyrosine kinase inhibitors (TKIs) but eventually exhibit acquired or innate resistance to the therapies typically due to gene mutations, such as EGFR T790M mutation or a second mutation in the downstream pathways of EGFR. Importantly, a significant portion of NSCLC patients shows TKI resistance without any known mechanisms, calling more comprehensive studies to reveal the underlying mechanisms. Here, we investigated a synthetic lethality with gefitinib using a genome-wide RNAi screen in TKI-resistant EGFR-mutant NSCLC cells, and identified RNF25 as a novel factor related to gefitinib resistance. Depletion of RNF25 expression substantially sensitized NSCLC cells to gefitinib treatment, while forced expression of RNF25 augmented gefitinib resistance in sensitive cells. We demonstrated that RNF25 mediates NF-κB activation in gefitinib-treated cells, which, in turn, induces reactivation of ERK signal to cause the drug resistance. We identified that the ERK reactivation occurs via the function of cytokines, such as IL-6, whose expression is transcriptionally induced in a gefitinib-dependent manner by RNF25-mediated NF-κB signals. These results suggest that RNF25 plays an essential role in gefitinib resistance of NSCLC by mediating cross-talk between NF-κB and ERK pathways, and provide a novel target for the combination therapy to overcome TKI resistance of NSCLC.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Resistencia a Antineoplásicos , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Gefitinib/uso terapéutico , Mutación/genética , FN-kappa B/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , Animales , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Resistencia a Antineoplásicos/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Receptores ErbB/genética , Femenino , Gefitinib/farmacología , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/patología , Ratones Endogámicos BALB C , Ratones Desnudos , Interferencia de ARNRESUMEN
Cystatin SN (CST1) is one of the several salivary cystatins that form tight equimolar complexes with cysteine proteases, such as the cathepsins. High expression of CST1 is correlated with advanced pTNM stage in gastric cancer. However, the functional role of CST1 in tumorigenesis has not been elucidated. In this study, we showed that CST1 was highly expressed in colon tumor tissues, compared with nontumor regions. Increased cell proliferation and invasiveness were observed in HCT116 cell lines stably transfected with CST1 cDNA (HCT116-CST1) but not in CST3-transfected cells. We also demonstrated that CST1-overexpressing cell lines exhibited increased tumor growth as well as metastasis in a xenograft nude mouse model. Interestingly, CST1 interacted with cystatin C (CST3), a potent cathepsin B (CTSB) inhibitor, with a higher affinity than the interaction between CST3 and CTSB in the extracellular space of HCT116 cells. CTSB-mediated cellular invasiveness and proteolytic activities were strongly inhibited by CST3, but in the presence of CST1 CTSB activities recovered significantly. Furthermore, domain mapping of CST1 showed that the disulfide-bonded conformation, or conserved folding, of CST1 is important for its secretion and for the neutralization of CST3 activity. These results suggest that CST1 upregulation might be involved in colorectal tumorigenesis and acts by neutralizing the inhibition of CTSB proteolytic activity by CST3.
Asunto(s)
Catepsina B/metabolismo , Cistatina C/metabolismo , Cistatinas Salivales/metabolismo , Animales , Western Blotting , Catepsina B/genética , Línea Celular , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Cistatina C/genética , Células HCT116 , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Microscopía Confocal , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Cistatinas Salivales/genéticaRESUMEN
Although the high transfection efficiency with adenovirus in vitro is well documented, it is still not clear whether adenoviral vectors are effective in vivo in solid tumor models. In our preliminary experiment, transduction of tumor tissue was limited to just around the injection site after intratumoral injection of the adenoviral vector. To improve the transduction efficiency in vivo, we tried a combination of adenoviral vector and liposome in our animal model. Adenovirus carrying human placental alkaline phosphatase (AdALP) and Lipofectamine or 1,3-di-oleoyloxy-2-(6-carboxyspermyl)-propylamide were used as a marker gene and the cationic liposome, respectively. A >15-fold increase in the transfection efficiency was observed in CT26 tumor cell lines with the combination of AdALP adenovirus carrying murine granulocyte-macrophage colony-stimulating factor (AdmGM-CSF), and liposome compared with adenovirus alone, showing the feasibility of the combination treatment. In the animal model, with the combination of liposome and AdALP, deeper and wider distribution of the marker gene in the tumor mass was shown. We conclude that the limitations of direct application of adenoviral vectors in a solid tumor model could be overcome by the use of cationic liposomes. This approach will facilitate the more effective delivery of adenoviral vectors in a clinical trial setting.
Asunto(s)
Adenocarcinoma/genética , Adenoviridae/genética , Neoplasias del Colon/genética , Transducción Genética/métodos , Adenocarcinoma/metabolismo , Adenocarcinoma/terapia , Fosfatasa Alcalina/metabolismo , Animales , Neoplasias del Colon/metabolismo , Neoplasias del Colon/terapia , Terapia Combinada , Cartilla de ADN/química , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Terapia Genética/métodos , Vectores Genéticos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Humanos , Técnicas In Vitro , Liposomas , Ratones , Ratones Endogámicos BALB C , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales CultivadasRESUMEN
A block copolymer composed of cationic polymer and poly(ethylene glycol) (PEG) was used as a DNA carrier. Poly(2-(dimethylamino)ethyl methacrylate (DMAEMA)-co-N-vinyl-2-pyrrolidone (NVP)) having a terminal carboxylic group was synthesized by free radical polymerization using an initiator, 4,4'-azobis(4-cyanovaleric acid). The terminal carboxylic acid was activated by N-hydroxysuccinimide (NHS) with dicyclohexylcarbodiimide (DCC) and then conjugated with PEG-bis(amine). For specific gene targeting to asialoglycoprotein receptor of hepatocytes, a galactose moiety was incorporated into the PEG terminal end of poly(DMAEMA-NVP)-b-PEG by reductive coupling using lactose and sodium cyanoborohydride. RSV luciferase plasmid was used as a reporter gene, and in vitro gene transfection efficiency was measured in HepG2 human hepatocarcinoma cells. Poly(DMAEMA-NVP)-b-PEG-galactose/DNA complexes formed at 0.5-2 polymer/plasmid weight ratio had compacted structures around 200 nm particle size and exhibited slightly negative surface charge. These complexes were coated with a cationic, pH sensitive, endosomolytic peptide, KALA, to generate positively charged poly(DMAEMA-NVP)-b-PEG-galactose/DNA/KALA complex particles. In the presence of serum proteins, both the PEG block and the galactose moiety of poly(DMAEMA-NVP)-b-PEG-galactose greatly enhanced the gene transfection efficiency, which was very close to that of Lipofectamine plus. Irrespective of the presence of serum proteins, as the KALA/DNA weight ratio increased, the transfection efficiency of poly(DMAEMA-NVP)-b-PEG-galactose was enhanced due to the pH dependent endosomal disruptive property of KALA. This study demonstrates that sufficient transfection efficiency as high as that of commercial agent could be attained by judicious formulation of molecular engineered poly(DMAEMA-NVP)-b-PEG-galactose in combination with an endosomolytic peptide, KALA.
Asunto(s)
Vectores Genéticos , Hepatocitos/metabolismo , Péptidos/síntesis química , Plásmidos/química , Polietilenglicoles/síntesis química , Polímeros/síntesis química , Pirrolidinonas/síntesis química , Transfección/métodos , Secuencia de Aminoácidos , Carcinoma Hepatocelular , Resinas de Intercambio de Catión , Supervivencia Celular/efectos de los fármacos , Genes Reporteros , Humanos , Indicadores y Reactivos , Lípidos , Neoplasias Hepáticas , Luciferasas/genética , Modelos Moleculares , Conformación Molecular , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Péptidos/química , Polietilenglicoles/química , Polietilenglicoles/toxicidad , Polímeros/química , Polímeros/toxicidad , Potenciometría , Pirrolidinonas/química , Pirrolidinonas/toxicidad , Propiedades de Superficie , Células Tumorales CultivadasRESUMEN
Gene transfer was performed using asialo-oroso-mucoid-polylysine (ASOR-PL) conjugates to allow targeted expression of the gene in cells of hepatic origin. In a gel-electrophoretic analysis, the ASOR-PL conjugate produced a complete DNA retardation effect at the optimal ratio of 222:1 (ASOR-PL conjugate/pCMV beta-gal plasmid). The gene-transfer efficiency of the ASOR-PL conjugate was evaluated in HepG2 cells that express asialoglycoprotein receptor and NIH 3T3 cells that do not. The expression was assayed by 5-bromo-4-chloroindol-3-yl beta-D-galactopyranoside ('X-Gal') staining and Chlorophenol Red beta-D-galactopyranoside. When an expression vector for the tumour-suppressor gene p53, pCMVp53, complexed to ASOR-PL conjugate, was transfected into HepG2 cells, the exogenously provided p53 gene was detected in the HepG2 cells by PCR. To improve the efficiency of DNA delivery and expression of the therapeutic proteins poloxamer 407, a fusogenic peptide, influenza-virus haemagglutinin HA2 and chloroquine were individually incorporated into the system. The expression level of beta-galactosidase in HepG2 cells was increased by about four times by the presence of poloxamer 407, whereas the fusogenic peptide HA2 and chloroquine had no effects. When HepG2 cells were transfected with pCMVp53 in the presence of poloxamer 407, the mRNA of transfected p53 could be detected by reverse transcriptase PCR. The current findings open the possibility that a receptor-mediated gene-delivery system for hepatic gene therapy using ASOR-PL conjugate in combination with poloxamer 407 may be developed in the future.
Asunto(s)
Asialoglicoproteínas/farmacología , Técnicas de Transferencia de Gen , Orosomucoide/análogos & derivados , Polilisina/farmacología , Células 3T3 , Secuencia de Aminoácidos , Animales , Receptor de Asialoglicoproteína , Carcinoma Hepatocelular/genética , Galactósidos/química , Humanos , Indoles/química , Neoplasias Hepáticas/genética , Ratones , Datos de Secuencia Molecular , Orosomucoide/farmacología , Fenolsulfonftaleína/análogos & derivados , Fenolsulfonftaleína/química , Plásmidos/genética , Poloxámero/química , Poloxámero/farmacología , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/metabolismo , Coloración y Etiquetado/métodos , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
We have investigated a new role of RhoA in the germinal vesicle breakdown (GVBD) of mouse oocytes. First, RhoA was identified by immunostaining and ADP-ribosylation in germinal vesicle (GV) stage-oocytes. RhoA was mainly localized in the ooplasmic area, but rarely detected in germinal vesicle. Incubation of oocyte extract with C3 transferase induced a strong ADP-ribosylation at about 25 kDa. Incubation of GV-stage oocytes in culture medium induced the spontaneous maturation to GVBD by about 78 and 87% of total oocytes at 1 and 3 h, respectively. However, microinjection of C3 transferase into GV-stage oocytes significantly inhibited GVBD at 1 (GVBD = 29%) and 3 h (GVBD = 49%). To study the role of reactive oxygen species (ROS) in the oocyte maturation, the level of intra-oocyte ROS was measured using a ROS-specific fluorescent dye H(2)DCFDA during the oocyte maturation. Spontaneous maturation of GV-stage oocytes induced a significant increase of ROS at 3 h by about twofold over the control level and then the increased level was maintained until 6 h. However, microinjection of C3 transferase inhibited the production of intra-oocyte ROS. Incubation with ROS scavengers, N-acetyl-l-cysteine and catalase, blocked the ROS increase. The ROS scavengers also significantly inhibited GVBD, as did C3 transferase. Thus, it was proposed that RhoA was involved in the GVBD, possibly by the production of ROS in mouse oocytes.
Asunto(s)
Toxinas Botulínicas , Oocitos/metabolismo , Proteína de Unión al GTP rhoA/metabolismo , ADP Ribosa Transferasas/farmacología , Animales , Ratones , Microinyecciones , Oocitos/citología , Oocitos/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismoRESUMEN
Based on the assumption that foreign DNA sequences may have increased chance of integration into the host genome if they are flanked by high copy-numbered genomic sequences such as SINEs (short interspersed elements), we investigated the integration frequency of Lac Z reporter gene flanked by a fused B1/B2 in an in vivo system using pronuclear microinjection technique in the mouse. The SINE-flanked DNA showed a 4-fold increased integration frequency of the reporter gene than the control DNA (63% vs. 16%). Moreover, the level of beta-galactosidase expression, estimated from the X-Gal staining intensity in transgenic embryos, was greatly higher in SINE-carrying DNA. These results suggest that the SINE sequences can serve a very useful tool in improving the efficiency of current transgenic animal technology.
Asunto(s)
Desarrollo Embrionario/fisiología , Genes Reporteros , Elementos de Nucleótido Esparcido Corto , beta-Galactosidasa/genética , Animales , ADN Superhelicoidal , Femenino , Expresión Génica , Ratones , Microinyecciones , Embarazo , TransgenesRESUMEN
We investigated whether mouse short interspersed elements (SINEs) could influence the recombination frequency of foreign DNA. Vectors harboring a reporter gene in combinations of SINEs B1 and/or B2 or a portion of long interspersed element-1 were prepared and tested in vitro by a colony assay using HC11 murine mammary epithelial cells and in vivo by microinjection into fertilized mouse eggs. In transfected HC11 cells, the number of colonies surviving G418 selection increased by 3.5-fold compared with control when the reporter was flanked by fused B1-B2 sequences. Similar results were obtained from microinjection study; in fetuses 11.5 days post coitum, transgene positives in control and SINE-flanked vectors were 16 and 53%, respectively. Individual B1- and B2-harboring vectors showed equivalent activities with each other, as determined by the colony assay (2.8-fold versus 3.2-fold compared with control). We determined the contribution of homologous recombination to the SINE-mediated increase in integration frequency through a polymerase chain reaction-based strategy; in more than half of embryos transgenes underwent homologous recombinations involving B1 sequences. These results demonstrate that the SINE sequences can increase the integration rate of foreign DNA and that such an increase is most likely due to the enhancement of homologous recombination.
Asunto(s)
ADN/genética , Recombinación Genética , Transfección , Animales , Secuencia de Bases , Vectores Genéticos , Ratones , Datos de Secuencia MolecularRESUMEN
To study whether we could enhance the liver targeting of DNA delivery via asialoglycoprotein receptors using a complex of poly-L-lysine (PLL)-condensed DNA and galactosylated bovine serum albumin (GalBSA) (GPD complex), DNA was first combined with PLL and then with GalBSA via charge interaction (GalBSA: PLL: DNA=3:0.5:1, w/w/w). This vector was characterized by dynamic laser light scattering, gel retardation assay, and electron microscopy to determine the particle size, electrostatic charge interaction, and 3-D structure. An electron micrography of GPD complex, where GalBSA: PLL: DNA=3:0.5:1 (w/w/w), showed a structure of spherical particles with a mean diameter of 145+/-24.2 nm, and the complex was positively charged. The complex was tested for specificity and efficiency of gene transfer in cultured human hepatoblastoma cell line Hep G2 and mouse fibroblast cells NIH/3T3 in vitro. Cellular uptake was specifically dependent on the abundance of galactose receptors on target cells. Hep G2 cells transfected with GPD complexed with the fusogenic peptide KALA (WEAKLAKALAKALAKHLAKALAKALKACEA) showed a significantly higher reporter gene activity than those transfected with GPD complex alone or free DNA-KALA complex. The efficiency of gene transfer mediated by GPD-KALA complex was not affected by the presence of serum in the transfection medium. The reporter gene activity in NIH/3T3 cells transfected with GPD complex was very low regardless of the presence of KALA and almost the same as that transfected with bovine serum albumin (BSA)-PLL-DNA complex (BPD complex). This gene transfer formulation may find potential applications for the gene therapy of liver diseases.
Asunto(s)
Albúminas/química , Técnicas de Transferencia de Gen , Hígado/metabolismo , Polilisina/química , Receptores de Superficie Celular/metabolismo , Células 3T3 , Secuencia de Aminoácidos , Animales , Receptor de Asialoglicoproteína , Bovinos , Galactosa/química , Humanos , Ratones , Datos de Secuencia Molecular , Células Tumorales CultivadasRESUMEN
Stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) is activated by a variety of cellular or environmental stresses. Proper regulation of the SAPK/JNK pathway may be critical for cell survival or death under various conditions. In this study, we report the molecular cloning of novel isoforms of JIP-1, which harbor a putative phosphotyrosine interaction domain and a helix-loop-helix domain, as well as an SH3 homologous region in the C terminus. Northern analysis indicates that transcription variant jip-1 is expressed in brain and kidney and transcription variants jip-2 and jip-3 are specifically expressed in brain. In situ hybridization data showed that the hybridized jip messages were heavily concentrated in adult brain, and were particularly enriched in the cerebral cortex and hippocampus, the brain regions vulnerable to pathological states such as hypoxia-ischemia, epilepsy, and Alzheimer's disease. All the deduced protein products of the jip transcription variants appear to have a similar property in that they inhibit the SAPK/JNK stimulation when overexpressed. Inhibition of SAPK activation by overexpression of the novel isoform JIP-2a resulted in suppression of etoposide-induced cell death in a neuroglioma cell line, N18TG. These findings suggest that JIP may play an important role in regulation of the SAPK pathway that is involved in stress-induced cellular responses.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Empalme Alternativo/fisiología , Química Encefálica/fisiología , Proteínas Portadoras/genética , Proteínas Quinasas JNK Activadas por Mitógenos , Quinasas de Proteína Quinasa Activadas por Mitógenos , Animales , Apoptosis/genética , Encéfalo/citología , Encéfalo/enzimología , Clonación Molecular , ADN Complementario/aislamiento & purificación , Regulación Enzimológica de la Expresión Génica , Biblioteca de Genes , MAP Quinasa Quinasa 4 , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Neuronas/citología , Neuronas/enzimología , Proteínas Quinasas/metabolismo , Homología de Secuencia de Aminoácido , Transducción de Señal/fisiología , Transcripción Genética/fisiologíaRESUMEN
The Pic-1, Oct-1,2, Unc-86 (POU) transcription factor Oct-4 is specifically expressed in the germ cell line, and a previous study has indicated that the expression of the lacZ gene inserted into an 18 kb genomic fragment encompassing the Oct-4 gene can come close to mimicking the endogenous embryonic expression pattern of Oct-4 in transgenic mice. In the present study transgenic mice expressing green fluorescent protein (GFP) in the germ cell line were generated using the same Oct-4 genomic fragments and the expression pattern was analyzed in detail through all stages of germ cell development. The GFP expressing primordial germ cells were first detected as early as 8.0 days post-coitum (d.p.c.; early head fold stage) at the base of the allantois in living embryos. The GFP expression was thereafter found in both male and female germ cells at all developmental stages except in male germ cells after differentiating into type A spermatogonia in the postnatal testis. There was also a lower level of expression in female germ cells in the prophase of the first meiotic division. These transgenic mice therefore proved to be powerful tools for isolating living germ cells at various developmental stages to study their nature and to isolate new genes.
Asunto(s)
Proteínas de Unión al ADN/genética , Células Germinativas/metabolismo , Proteínas Luminiscentes/genética , Animales , Blastocisto/metabolismo , Diferenciación Celular , Femenino , Regulación del Desarrollo de la Expresión Génica , Genes Reporteros , Proteínas Fluorescentes Verdes , Masculino , Ratones , Ratones Transgénicos , Microscopía Fluorescente , Factor 3 de Transcripción de Unión a Octámeros , Factores de TranscripciónRESUMEN
Peroxiredoxins (Prxs) are a newly defined family of antioxidant proteins that have been implicated, via their antioxidant activity, in a number of cellular functions, including cell proliferation and differentiation, protection of other proteins from oxidative damage, and intracellular signaling. We isolated genomic DNA sequences of the type II Prx (Prx II) gene from the mouse and analyzed their molecular genetic characteristics. In the mouse, the Prx II is found to form a small multigene family with three members. One of them, the Prx II-1 gene, is actively transcribed in a variety of adult tissues as well as in the developing embryos to produce a 1.1-kb mRNA. The Prx II-1 gene consists of six exons and five introns, and the whole transcription unit occupies about 4.5 kb in the mouse genome. The other two genes, Prx II-2 and Prx II-3, are encoded by single exons, and show 97.5 and 87% of nucleotide sequence homology with the Prx II-1 gene, respectively. Structural features of these genes and the results of RT-PCR analysis on RNAs from various tissue sources indicate that the Prx II-2 and Prx II-3 genes could be pseudogenes derived from the Prx II-1 gene by a mechanism involving retrotransposition. These results strongly suggest that only the Prx II-1 gene might be relevant for studying the function of the Prx II gene in the murine system.
Asunto(s)
Genes/genética , Familia de Multigenes/genética , Peroxidasas/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , ADN/química , ADN/genética , ADN Complementario/química , ADN Complementario/genética , Evolución Molecular , Exones/genética , Expresión Génica/genética , Regulación del Desarrollo de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Intrones/genética , Ratones , Datos de Secuencia Molecular , Peroxirredoxinas , Fosfolipasas A/genética , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Distribución TisularRESUMEN
The totipotent stem cells of the pregastrulation mouse embryo which give rise to all embryonic somatic tissues and germ cells express Oct-4. The expression is downregulated during gastrulation and is thereafter only maintained in the germline lineage. Oct-4/lacZ transgenes were used to determine how this pattern of expression was achieved, and resulted in the identification of two separate regulatory elements. The distal element drives Oct-4 expression in preimplantation embryos, in migratory and postmigratory primordial germ cells but is inactive in cells of the epiblast. In cell lines this element is specifically active in embryonic stem and embryonic germ cells. The proximal element directs the epiblast-specific expression pattern, including downregulation during gastrulation; in cell lines its activity is restricted to epiblast-derived cells. Thus, Oct-4 expression in the germline is regulated separately from epiblast expression. This provides the first marker for the identification of totipotent cells in the embryo, and suggests that expression of Oct-4 in the totipotent cycle is dependent on a set of factors unique to the germline.
Asunto(s)
Proteínas de Unión al ADN/genética , Células Germinativas/fisiología , Factores de Transcripción , Animales , Secuencia de Bases , Cartilla de ADN/química , Proteínas de Unión al ADN/metabolismo , Implantación del Embrión , Elementos de Facilitación Genéticos , Femenino , Gástrula/fisiología , Regulación del Desarrollo de la Expresión Génica , Masculino , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Factor 3 de Transcripción de Unión a Octámeros , ARN Mensajero/genética , Células MadreRESUMEN
Oct3/4, a hallmark of the earliest stages of embryogenesis, is expressed in undifferentiated embryonal carcinoma (EC) and embryonic stem (ES) cells. Oct3/4 gene expression is dependent on the promoter region, the proximal enhancer and the newly identified distal enhancer. We have analysed in vivo occupancy of these elements. In undifferentiated EC and ES cells, strong footprints were detected at specific sites of all three regulatory elements. These were promptly lost upon RA treatment in ES cells and in P19 EC cells, in parallel with sharply reduced Oct3/4 mRNA levels. Thus, the occupancy of regulatory elements is coupled with Oct3/4 expression, and RA treatment causes coordinated factor displacement, leading to extinction of gene activity. In F9 EC cells, footprint was first abolished at the proximal enhancer. However, this loss of binding site occupancy did not result in a decrease in Oct3/4 mRNA levels. The partial factor displacement seen in F9 EC cells, combined with the observation that EC and ES cells utilize the proximal and distal enhancers in differential manner, indicate the complex pattern of Oct3/4 gene regulation, which could reflect a cell type- and lineage-specific expression of the gene in vivo.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Factores de Transcripción/metabolismo , Tretinoina/farmacología , Animales , Secuencia de Bases , Núcleo Celular/metabolismo , Cartilla de ADN/química , Regulación hacia Abajo , Regulación de la Expresión Génica , Genes , Células L , Ratones , Datos de Secuencia Molecular , Factor 3 de Transcripción de Unión a Octámeros , Regiones Promotoras Genéticas , Unión Proteica , ARN Mensajero/genética , Transcripción Genética/efectos de los fármacos , Células Tumorales CultivadasRESUMEN
Active gene transcription is known to promote genetic change in neighboring DNA. We reasoned that the change would be readily heritable if transcription was occurring in germ cells or early embryonic cells before the germ cells are set aside. The H-2K region of the major histocompatibility complex (MHC) provides a good vehicle for testing this hypothesis because it is replete with such genes. We have compared the amount of polymorphism in 240 kb of DNA contiguous with H-2K and 150 kb of DNA flanking a homologous duplicated region in t-haplotypes and inbred strains. Using 90 probes and three restriction enzymes, we find a staggering difference in the amount of polymorphism in the H-2K region vs. the duplicated region (26% vs. 0%) of t-haplotypes. The disparity in the rate of divergence between the two regions indicates that the spatial distribution of genes and their expression pattern might be important factors in sequence evolution. Since t-haplotypes normally show extremely limited variability among themselves due to their recent divergence from a single ancestor, these results imply that the mutation rate in the H-2K region is unusually high. This is in apparent contradiction to the current view that the MHC loci have evolved at the same rate as other loci. The implications for the evolution of the H-2K gene are discussed.
Asunto(s)
Evolución Biológica , Antígenos H-2/genética , Péptidos y Proteínas de Señalización Intracelular , Ratones/genética , Proteínas Asociadas a Microtúbulos , Mutación , Transcripción Genética , Animales , Southern Blotting , Embrión de Mamíferos/metabolismo , Expresión Génica , Prueba de Complementación Genética , Variación Genética , Células Germinativas/metabolismo , Haplotipos , Cinética , Ratones/embriología , Ratones/inmunología , Ratones Endogámicos C3H , Familia de Multigenes , Proteínas Nucleares/genética , Polimorfismo de Longitud del Fragmento de Restricción , Ubiquitina-Proteína Ligasas , Región del Complejo T del GenomaRESUMEN
The major histocompatibility complex (MHC) of the mouse is located on chromosome 17 in the distal inversion of the t complex. In addition to genes playing major roles in the immune response, it contains a diversity of genes. In humans, numerous diseases are known to be associated with the MHC loci. Moreover, at least three recessive embryonic t-lethal mutations have been mapped to the MHC. Here a molecular genetic approach was used to study the detailed genomic structure of 240 kilobases (kb) surrounding the H-2K gene and 150 kb of a partly homologous region located in the distal inversion of the t complex. Combined with previous findings, the H-2K region was found to contain an impressively high density of genes--12 transcription units in 240 kb. Surprisingly, virtually all of these genes are expressed in testis and/or embryos. The genomic organization of this region is contrasted with the 150 kb of the homologous area where only three genes and an endogenous retrovirus reside.
Asunto(s)
Genes MHC Clase I/genética , Complejo Mayor de Histocompatibilidad , Ratones/genética , Animales , Northern Blotting , Southern Blotting , Mapeo Cromosómico , Expresión Génica , Genes , Ligamiento Genético , Masculino , Ratones/embriología , ARN Mensajero/genética , Mapeo Restrictivo , Testículo/fisiología , Transcripción GenéticaRESUMEN
The map position of Oct-4 on mouse chromosome 17 is between Q and T regions in the Major Histocompatibility Complex (MHC), and it is physically located within 35 kb of a class I gene. Several Oct-4-related genes are present in the murine genome; one of them maps to chromosome 9. The genomic structure and sequence of Oct-4 determined in t-haplotypes reveals five exons, and shows no significant changes in the t12 mutant haplotype making it unlikely that Oct-4 and the t12 early embryonic lethal are the same gene. By in situ hybridization, detectable onset of zygotic Oct-4 expression does not occur until compaction begins at 8-cells, suggesting that there might be other regulatory factors responsible for initiating Oct-4 expression.
Asunto(s)
Mapeo Cromosómico , Proteínas de Unión al ADN/genética , Factores de Transcripción/genética , Animales , Secuencia de Bases , Southern Blotting , Clonación Molecular , Cósmidos , ADN , Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/ultraestructura , Electroforesis en Gel de Campo Pulsado , Expresión Génica , Complejo Mayor de Histocompatibilidad , Ratones , Ratones Endogámicos , Datos de Secuencia Molecular , Familia de Multigenes , Factor 3 de Transcripción de Unión a Octámeros , Reacción en Cadena de la Polimerasa , Cigoto/metabolismoRESUMEN
The t-complex of the mouse occupies the proximal half of chromosome 17 and contains genes which have profound effects on spermatogenesis. Mutations of several loci in the t-complex appear to interact to cause male sterility or transmission ratio distortion (TRD). By cDNA screening or chromosomal walking we have identified seven genes, which are expressed in the germ cells of testis and map to various regions of the t-complex. These genes were named t-complex testis-expressed (Tctex) genes. An analysis of their expression patterns in testes from +/+, +/t, and t/t mice was done by in situ hybridization and by northern blotting. Six genes begin to be expressed at the pachytene stage: Three of them are more abundant at pachytene stage, while three others are more abundant at postmeiotic stages. One gene is expressed at all the stages of spermatogenesis. Interestingly, four Tctex genes show differences in the amount of transcript between wild-type and t-mutant testes. The chromosomal location and expression pattern imply that Tctex genes might be candidate genes for sterility or TRD.
Asunto(s)
Péptidos y Proteínas de Señalización Intracelular , Proteínas Asociadas a Microtúbulos , Proteínas Nucleares/genética , Testículo/metabolismo , Animales , Mapeo Cromosómico , ADN/genética , Femenino , Expresión Génica , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Mutantes , Oogénesis/genética , ARN/genética , Espermatogénesis/genética , Hormonas Testiculares/genética , Testículo/crecimiento & desarrollo , Ubiquitina-Proteína Ligasas , Región del Complejo T del GenomaRESUMEN
Immobilization of urokinase, a plasminogen activator, was carried out to determine the effect of spacer length used on the immobilized enzyme activity. The enzyme was covalently coupled to agarose gel, both directly to the matrix and also via interposing different lengths of spacer groups. The specific activity of immobilized urokinase increased as the spacer length (n') increased to a certain length and tended to decrease thereafter. The maximal activity was shown when the value of n' was 7 for the agarose-NH-(CH2)n-CO-NH-(CH2)2-CO-NH-urokinase series. The coupling yield of the enzyme activity was from 33 to 68% depending on various forms of immobilized urokinase. The immobilized urokinase was characterized with regard to pH, temperature, storage, and thermal stabilities.